{"id":49369,"date":"2021-07-01T10:04:38","date_gmt":"2021-07-01T14:04:38","guid":{"rendered":"https:\/\/piel-l.org\/blog\/?p=49369"},"modified":"2021-07-01T10:04:38","modified_gmt":"2021-07-01T14:04:38","slug":"therapeutics-and-covid-19-living-guideline-who","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/49369","title":{"rendered":"Therapeutics and COVID-19: living guideline (WHO)"},"content":{"rendered":"<p><strong>World Health Organization (WHO)<\/strong><br \/>\nEnviado gentilmente por Dra. Olga Zerpa<\/p>\n<p><!--more--><\/p>\n<blockquote><p><em>La Dra. Olga Zerpa con una brillante carrera en nuestra especialidad en Leishmaniasis y afecciones dermatologicas que representan un problema de salud, se encuentra actualmente trabajando en Whashington DC USA, como \u201c<strong>Associate Editor Pan American Journal of Public Health. PAHO-WHO<\/strong>\u201d y esta iniciando una maestria en Johns Hopkins en salud p\u00fablica, \u201c<strong> Patient Safety and Quality Health Care improvement<\/strong>\u201d. Su labor en la OPS \u2013 OMS podr\u00e1 aportarnos a los lectores de Piel Latinoamericana una importante informaci\u00f3n en el campo de la salud publica<\/em><\/p><\/blockquote>\n<div><span style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-therapeutics-2021.1\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-therapeutics-2021.1&amp;source=gmail&amp;ust=1625234364780000&amp;usg=AFQjCNGEcFaFW6ZLvoxvNgn0tfXGR8T2GA\">https:\/\/www.who.int\/<wbr \/>publications\/i\/item\/WHO-2019-<wbr \/>nCoV-therapeutics-2021.1<\/a><\/span><\/div>\n<div>Esta es una gu\u00eda que actualizan semanalmene y siempre esta en vivo<\/div>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>World Health Organization (WHO) Enviado gentilmente por Dra. Olga Zerpa<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"class_list":["post-49369","post","type-post","status-publish","format-standard","","category-comunicaciones-importantes"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/49369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=49369"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/49369\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=49369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=49369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=49369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}